Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -328.73% is 93% below its 5-year average of -169.99%, around the middle of its 5-year range (-574.33%–-0.65%).
11.09% above its 12-month average of -369.72%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -83.63%.
RETURN ON ASSETS (ROA)
-328.73%
RETURN ON ASSETS (ROA) AVG TTM
-369.72%
RETURN ON ASSETS (ROA) AVG 3Y
-216.98%
RETURN ON ASSETS (ROA) AVG 5Y
-169.99%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+11.09%
CURRENT VS 3Y AVG
-51.50%
CURRENT VS 5Y AVG
-93.39%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-919.63%
vs the sector median at left
Silexion Therapeutics Ltd.
Market Cap
$109735.00
Return on Assets (ROA)
-328.73%
TTM Avg
-369.72%
3Y Avg
-216.98%
5Y Avg
-169.99%
Market Cap
$95097.00
Return on Assets (ROA)
N/A
TTM Avg
-12.82%
3Y Avg
-1135.32%
5Y Avg
-756.46%
Market Cap
$70876.00
Return on Assets (ROA)
-46.60%
TTM Avg
-181.35%
3Y Avg
-132.03%
5Y Avg
-98.15%
Market Cap
$61175.00
Return on Assets (ROA)
-736.88%
TTM Avg
-394.32%
3Y Avg
-295.91%
5Y Avg
-223.09%
Market Cap
$30924.00
Return on Assets (ROA)
-25.95%
TTM Avg
-14.21%
3Y Avg
-20.62%
5Y Avg
-11.50%
Market Cap
$29886.00
Return on Assets (ROA)
-73.13%
TTM Avg
-134.69%
3Y Avg
-84.14%
5Y Avg
-80.58%
Market Cap
$6008.00
Return on Assets (ROA)
N/A
TTM Avg
7.76%
3Y Avg
8.55%
5Y Avg
6.83%
Market Cap
$245237.00
Return on Assets (ROA)
-159.79%
TTM Avg
-110.26%
3Y Avg
-72.69%
5Y Avg
-81.04%
Market Cap
$380715.00
Return on Assets (ROA)
-60.35%
TTM Avg
-77.33%
3Y Avg
-83.27%
5Y Avg
-755.53%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Silexion Therapeutics Ltd. (SLXN) | $109735.00 | -328.73% | -369.72% | -216.98% | -169.99% |
| Psyence Biomedical Ltd. (PBM)vs › | $95097.00 | N/A | -12.82% | -1135.32% | -756.46% |
| PRF Technologies Ltd. (PRFX)vs › | $70876.00 | -46.60% | -181.35% | -132.03% | -98.15% |
| Akanda Corp. (AKAN)vs › | $61175.00 | -736.88% | -394.32% | -295.91% | -223.09% |
| Zhongchao Inc. (ZCMD)vs › | $30924.00 | -25.95% | -14.21% | -20.62% | -11.50% |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $29886.00 | -73.13% | -134.69% | -84.14% | -80.58% |
| NewGenIvf Group Limited (NIVF)vs › | $6008.00 | N/A | 7.76% | 8.55% | 6.83% |
| SciSparc Ltd. (SPRC)vs › | $245237.00 | -159.79% | -110.26% | -72.69% | -81.04% |
| Virax Biolabs Group Limited (VRAX)vs › | $380715.00 | -60.35% | -77.33% | -83.27% | -755.53% |
| Niki BioSolutions, Inc. (NIKI)vs › | $381940.00 | -7.29% | -16.88% | -23.60% | -32.13% |
ROA
-328.7%
ROE
-31722.7%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -165.10% |
| 2024-12-31 | -574.33% |
| 2023-12-31 | -94.03% |
| 2022-12-31 | -34.45% |
| 2021-12-31 | -0.65% |
| 2020-12-31 | -151.36% |
